Posted in | News | Gold | Mining Business

LKA Gold to Test Newly Discovered Surface Anomalies in Third Quarter of 2015

LKA Gold Incorporated A surface drilling program planned for early summer, 2016, is expected to test three recently discovered surface anomalies (previously announced) identified by Kinross geologists in the third quarter of 2015.

According to a detailed report provided to LKA by Kinross Gold USA earlier this year, these anomalies ("drill targets") are situated at intersections of the main Golden Wonder vein structure and three highly mineralized oblique fault zones. Soil sampling data indicates that all three targets possess geochemistry strikingly similar to that found directly above the previously mined, bonanza-grade, ore shoot at the Golden Wonder. The closest target is located adjacent to the existing high-grade zone with the furthest located, on strike, over 1,000 meters away. All drill targets are situated within LKA's claim package.

According to LKA President, Kye Abraham, "We're anxious to get the drilling program underway. A high-grade gold discovery at any one of these three targets would confirm our belief that LKA's property is host to multiple ore shoots…possibly of the same bonanza ore grade encountered in the first one. We'll know more soon."

The views expressed in this press release are solely those of LKA management upon examination of the Kinross report. More discussion on the LKA-Kinross exploration agreement and related subjects can be found in the "President's Email Updates" and "President's Archive" on the Company's website at: http://lkagold.com/Management_Team_-_LKA_Inter.html. Details of Golden Wonder commercial and exploratory ore shipments can also be found on the Home Page of the Company's website at: www.lkagold.com

Source: http://www.lkagold.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.